Cas:53164-36-6 7,8-dimethyl-4-oxo-1H-quinoline-3-carboxylic acid manufacturer & supplier

Chemical Name:7,8-dimethyl-4-oxo-1H-quinoline-3-carboxylic acid

CAS.NO:53164-36-6

Synonyms:4-hydroxy-7,8-dimethylquinoline-3-carboxylic acid;7,8-Dimethyl-4-hydroxyquinoline-3-carboxylic acid;7,8-dimethyl-4-oxohydroquinoline-3-carboxylic acid

Molecular Formula:C₁₂H₁₁NO₃

Molecular Weight:217.22100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:398.6ºC at 760 mmHg

Density:1.317g/cm3

Index of Refraction:1.611

PSA:70.42000

Exact Mass:217.07400

LogP:2.25540

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 4-hydroxy-7,8-dimethylquinoline-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7,8-dimethyl-4-oxohydroquinoline-3-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7,8-dimethyl-4-oxohydroquinoline-3-carboxylic acid Use and application,7,8-dimethyl-4-oxohydroquinoline-3-carboxylic acid technical grade,usp/ep/jp grade.

Related News: DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. 7,8-dimethyl-4-oxo-1H-quinoline-3-carboxylic acid manufacturer The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 7,8-dimethyl-4-oxo-1H-quinoline-3-carboxylic acid supplier But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. 7,8-dimethyl-4-oxo-1H-quinoline-3-carboxylic acid vendor DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. 7,8-dimethyl-4-oxo-1H-quinoline-3-carboxylic acid factory In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum.